⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9342 | 0.96 | — | — | |
| SCHEMBL20141641 | 0.93 | — | — | |
| SCHEMBL20141352 | 0.93 | — | — | |
| SCHEMBL664039 | 0.74 | — | — | |
| SCHEMBL293898 | 0.69 | — | — | |
| SCHEMBL11372052 | 0.69 | — | — | |
| SCHEMBL1031834 | 0.69 | — | — | |
| SCHEMBL41539 | 0.69 | — | — | |
| SCHEMBL1498735 | 0.69 | — | — | |
| SCHEMBL16872607 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6627656-B2 | Antagonists of the pain and inflammatory effects of E-type prostaglandins administered alone or in combination with analgesics, antipyretics, NSAIDs, antitussives, decongestants etc | MERCK FROSST CANADA LTD. (CA) | 2003-09-30 | — | — | US | disclosed |
| EP-1278734-A2 | METHOD OF TREATMENT USING PHENYL AND BIARYL DERIVATIVES AS PROSTAGLANDIN E INHIBITORS AND COMPOUNDS USEFUL THEREFORE | Merck Frosst Canada & Co. (CA) | 2003-01-29 | — | — | EP | disclosed |
| US-20020082266-A1 | Method of treatment using phenyl and biaryl derivatives as prostaglandin E inhibitors and compounds useful therefore | MERCK FROSST CANADA LTD. (CA) | 2002-06-27 | — | — | US | disclosed |
| WO-2001081312-A2 | METHOD OF TREATMENT USING PHENYL AND BIARYL DERIVATIVES AS PROSTAGLANDIN E INHIBITORS AND COMPOUNDS USEFUL THEREFORE | MERCK FROSST CANADA & CO. (CA) | 2001-11-01 | — | — | WO | disclosed |